In most human malignancies, tumors develop through a series of genetic alterations, in contrast to the normal function of the p53 family gene (1–3); this procedure was identified as a tumor-driven progression to promote invasion, proliferation, cell survival, and drug resistance (4–6). Here, TP53 is linked to neoplasm.